CF
PTCT icon

CNA Financial’s PTC Therapeutics PTCT Stock Holding History

CNA Financial’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,190
Closed -$482K – 205
2021
Q1 		$482K Sell
10,190
-440
-4% -$26.1K 0.15% 162
2020
Q4 		$649K Buy
10,630
+240
+2% +$14.1K 0.2% 138
2020
Q3 		$486K Buy
10,390
+930
+10% +$45.8K 0.18% 132
2020
Q2 		$480K Buy
+9,460
New +$465K 0.19% 123

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

CNA Financial's PTCT Position: Q2 2021 in Review

CNA Financial sold out of PTC Therapeutics (PTCT) in Q2 2021, closing a stake of 10,190 shares — an estimated $482K sold.

CNA Financial first reported a position in PTCT in Q2 2020 and held it in 4 quarters. The position peaked at $649K in Q4 2020. 182 funds tracked by Wall St. Rank hold PTCT as of Q2 2021.

  • CNA Financial reported no remaining PTC Therapeutics position as of Q2 2021 after selling out during the quarter.
  • CNA Financial sold 10,190 PTC Therapeutics shares in Q2 2021, an estimated $482K.
  • CNA Financial first reported a position in PTC Therapeutics in Q2 2020 and held it in 4 quarters.
  • CNA Financial's PTC Therapeutics position peaked at $649K in Q4 2020.
  • 182 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2021.

Based on CNA Financial's 13F filing for Q2 2021, filed 12 Aug 2021.